PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
News|Articles|September 2, 2017
- Pharmaceutical Technology-09-02-2017
- Volume 41
- Issue 9
Industrial Vacuum for Fine Powders and Combustible Dusts
Vac-U-Max’s MDL15 combustible dust air-vac offers high-volume cleanup of powders and combustible dusts from floors, walls, machinery, and overhead surfaces.
Vac-U-Max’s MDL15 combustible dust air-vac offers high-volume cleanup of powders and combustible dusts from floors, walls, machinery, and overhead surfaces. The vacuum’s features include manual blow-back filter cleaning with static-conductive PTFE pre-filter and secondary cartridge filter, and static-conductive casters. Dust, debris, and fine powders are collected in “off-the-shelf” static-conductive polybags, eliminating “the mushroom cloud” that comes with drum dumping. Standard construction includes anti-sparking stainless steel in 304SS or 316SS bead-blast finish. The device is equipped with a static-conductive compressed-air hose, ATEX-certified vacuum hose, and complete cleaning tool kit assembly for floors, walls, machinery, and overhead cleaning. The vacuum uses the company’s Venturi power unit, which allows for low compressed-air consumption with no electricity required. The unit offers suction power at 16 in. Hg (208 in. H20), with Air Flow of 100 SCFM, requiring 35 SCFM at 60 PSI. Suction connection is 1.5 in. in diameter, with compressed-air connection at half inch NPT (Female). Noise levels are below 79 DBA at 8 in. Hg. Bonding and grounding requirements meet NFPA 77-2007 “Recommended Practice on Static Electricity” standard. The device also is suitable for Class II, Division 2 environments.
Articles in this issue
about 9 years ago
The Role of the Quality Unitabout 9 years ago
Manufacturing Standards Key to Advancing Cellular and Gene Therapiesabout 9 years ago
Using Simulation to Address Capacity Limitationsabout 9 years ago
Scaling Up a Continuous Granulation Processabout 9 years ago
The Human Cost of Congressional Stalematesabout 9 years ago
Expediting the Discovery and Development of Drugsabout 9 years ago
Stepping Up the Pace of Drug Stability Studiesabout 9 years ago
Top Trends in Biopharmaceutical Manufacturing, 2017about 9 years ago
A QbD-Based Approach to Drug Packaging and Deliveryabout 9 years ago
Targeting the LungsRelated to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.